Amicus Therapeutics Stock Price Prediction
| FOLD Stock | USD 14.28 0.01 0.07% |
Momentum 89
Buy Peaked
Oversold | Overbought |
EPS Estimate Next Quarter 0.1684 | EPS Estimate Current Year 0.3784 | EPS Estimate Next Year 0.6474 | Wall Street Target Price 14.5 | EPS Estimate Current Quarter 0.1224 |
Using Amicus Therapeutics hype-based prediction, you can estimate the value of Amicus Therapeutics from the perspective of Amicus Therapeutics response to recently generated media hype and the effects of current headlines on its competitors. We also analyze overall investor sentiment towards Amicus Therapeutics using Amicus Therapeutics' stock options and short interest. It helps to benchmark the overall future attitude of investors towards Amicus using crowd psychology based on the activity and movement of Amicus Therapeutics' stock price.
Amicus Therapeutics Short Interest
A significant increase or decrease in Amicus Therapeutics' short interest from the previous month could be a good indicator of investor sentiment towards Amicus. Short interest can provide insight into the potential direction of Amicus Therapeutics stock and how bullish or bearish investors feel about the market overall.
200 Day MA 8.3761 | Short Percent 0.0631 | Short Ratio 0.96 | Shares Short Prior Month 19.1 M | 50 Day MA 12.12 |
Amicus Therapeutics Hype to Price Pattern
Investor biases related to Amicus Therapeutics' public news can be used to forecast risks associated with an investment in Amicus. The trend in average sentiment can be used to explain how an investor holding Amicus can time the market purely based on public headlines and social activities around Amicus Therapeutics. Please note that most equities that are difficult to arbitrage are affected by market sentiment the most.
Some investors profit by finding stocks that are overvalued or undervalued based on market sentiment. The correlation of Amicus Therapeutics' market sentiment to its price can help taders to make decisions based on the overall investors consensus about Amicus Therapeutics.
Amicus Therapeutics Implied Volatility | 1.13 |
Amicus Therapeutics' implied volatility exposes the market's sentiment of Amicus Therapeutics stock's possible movements over time. However, it does not forecast the overall direction of its price. In a nutshell, if Amicus Therapeutics' implied volatility is high, the market thinks the stock has potential for high price swings in either direction. On the other hand, the low implied volatility suggests that Amicus Therapeutics stock will not fluctuate a lot when Amicus Therapeutics' options are near their expiration.
The fear of missing out, i.e., FOMO, can cause potential investors in Amicus Therapeutics to buy its stock at a price that has no basis in reality. In that case, they are not buying Amicus because the equity is a good investment, but because they need to do something to avoid the feeling of missing out. On the other hand, investors will often sell stocks at prices well below their value during bear markets because they need to stop feeling the pain of losing money.
Amicus Therapeutics after-hype prediction price | USD 14.28 |
There is no one specific way to measure market sentiment using hype analysis or a similar predictive technique. This prediction method should be used in combination with more fundamental and traditional techniques such as stock price forecasting, technical analysis, analysts consensus, earnings estimates, and various momentum models.
Prediction based on Rule 16 of the current Amicus contract
Based on the Rule 16, the options market is currently suggesting that Amicus Therapeutics will have an average daily up or down price movement of about 0.0706% per day over the life of the 2026-04-17 option contract. With Amicus Therapeutics trading at USD 14.28, that is roughly USD 0.0101 . If you think that the market is fully incorporating Amicus Therapeutics' daily price movement you should consider acquiring Amicus Therapeutics options at the current volatility level of 1.13%. But if you have an opposite viewpoint you should avoid it and even consider selling them.
Check out Amicus Therapeutics Basic Forecasting Models to cross-verify your projections. Amicus Therapeutics After-Hype Price Density Analysis
As far as predicting the price of Amicus Therapeutics at your current risk attitude, this probability distribution graph shows the chance that the prediction will fall between or within a specific range. We use this chart to confirm that your returns on investing in Amicus Therapeutics or, for that matter, your successful expectations of its future price, cannot be replicated consistently. Please note, a large amount of money has been lost over the years by many investors who confused the symmetrical distributions of Stock prices, such as prices of Amicus Therapeutics, with the unreliable approximations that try to describe financial returns.
Next price density |
| Expected price to next headline |
Amicus Therapeutics Estimiated After-Hype Price Volatility
In the context of predicting Amicus Therapeutics' stock value on the day after the next significant headline, we show statistically significant boundaries of downside and upside scenarios based on Amicus Therapeutics' historical news coverage. Amicus Therapeutics' after-hype downside and upside margins for the prediction period are 10.19 and 18.37, respectively. We have considered Amicus Therapeutics' daily market price in relation to the headlines to evaluate this method's predictive performance. Remember, however, there is no scientific proof or empirical evidence that news-based prediction models outperform traditional linear, nonlinear models or artificial intelligence models to provide accurate predictions consistently.
Current Value
Amicus Therapeutics is somewhat reliable at this time. Analysis and calculation of next after-hype price of Amicus Therapeutics is based on 3 months time horizon.
Amicus Therapeutics Stock Price Outlook Analysis
Have you ever been surprised when a price of a Company such as Amicus Therapeutics is soaring high without any particular reason? This is usually happening because many institutional investors are aggressively trading Amicus Therapeutics backward and forwards among themselves. Have you ever observed a lot of a particular company's price movement is driven by press releases or news about the company that has nothing to do with actual earnings? Usually, hype to individual companies acts as price momentum. If not enough favorable publicity is forthcoming, the Stock price eventually runs out of speed. So, the rule of thumb here is that as long as this news hype has nothing to do with immediate earnings, you should pay more attention to it. If you see this tendency with Amicus Therapeutics, there might be something going there, and it might present an excellent short sale opportunity.
| Expected Return | Period Volatility | Hype Elasticity | Related Elasticity | News Density | Related Density | Expected Hype |
0.84 | 4.12 | 0.05 | 0.51 | 22 Events / Month | 8 Events / Month | In about 22 days |
| Latest traded price | Expected after-news price | Potential return on next major news | Average after-hype volatility | |
14.28 | 14.28 | 0.00 |
|
Amicus Therapeutics Hype Timeline
Amicus Therapeutics is currently traded for 14.28. The entity has historical hype elasticity of -0.05, and average elasticity to hype of competition of 0.51. Amicus is expected not to react to the next headline, with the price staying at about the same level, and average media hype impact volatility is over 100%. The immediate return on the next news is expected to be very small, whereas the daily expected return is currently at 0.84%. %. The volatility of related hype on Amicus Therapeutics is about 684.39%, with the expected price after the next announcement by competition of 14.79. About 99.0% of the company shares are owned by institutional investors. The company recorded a loss per share of 0.04. Amicus Therapeutics last dividend was issued on the 31st of August 2009. Given the investment horizon of 90 days the next expected press release will be in about 22 days. Check out Amicus Therapeutics Basic Forecasting Models to cross-verify your projections.Amicus Therapeutics Related Hype Analysis
Having access to credible news sources related to Amicus Therapeutics' direct competition is more important than ever and may enhance your ability to predict Amicus Therapeutics' future price movements. Getting to know how Amicus Therapeutics' peers react to changing market sentiment, related social signals, and mainstream news is a great way to find investing opportunities and time the market. The summary table below summarizes the essential lagging indicators that can help you analyze how Amicus Therapeutics may potentially react to the hype associated with one of its peers.
| HypeElasticity | NewsDensity | SemiDeviation | InformationRatio | PotentialUpside | ValueAt Risk | MaximumDrawdown | |||
| IDYA | Ideaya Biosciences | 0.21 | 10 per month | 2.02 | 0.08 | 4.86 | (3.68) | 15.68 | |
| SRRK | Scholar Rock Holding | 1.56 | 11 per month | 2.42 | 0.15 | 5.92 | (4.21) | 31.68 | |
| ADPT | Adaptive Biotechnologies Corp | (0.12) | 13 per month | 3.84 | 0.03 | 9.94 | (4.95) | 29.55 | |
| ARQT | Arcutis Biotherapeutics | (0.39) | 10 per month | 2.12 | 0.08 | 6.75 | (3.47) | 32.59 | |
| CDTX | Cidara Therapeutics | (0.39) | 5 per month | 1.30 | 0.13 | 5.93 | (4.54) | 105.72 | |
| MLYS | Mineralys Therapeutics Common | (0.06) | 14 per month | 0.00 | (0.09) | 5.87 | (6.28) | 24.81 | |
| KNSA | Kiniksa Pharmaceuticals | 0.52 | 10 per month | 2.16 | 0.05 | 3.93 | (3.74) | 10.42 | |
| TARS | Tarsus Pharmaceuticals | 3.81 | 10 per month | 0.00 | (0.06) | 3.78 | (3.76) | 10.59 | |
| LEGN | Legend Biotech Corp | 1.10 | 10 per month | 0.00 | (0.28) | 3.83 | (6.84) | 19.65 | |
| CPRX | Catalyst Pharmaceuticals | (0.22) | 7 per month | 1.52 | 0.09 | 3.00 | (3.08) | 10.89 |
Amicus Therapeutics Additional Predictive Modules
Most predictive techniques to examine Amicus price help traders to determine how to time the market. We provide a combination of tools to recognize potential entry and exit points for Amicus using various technical indicators. When you analyze Amicus charts, please remember that the event formation may indicate an entry point for a short seller, and look at other indicators across different periods to confirm that a breakdown or reversion is likely to occur.| Cycle Indicators | ||
| Math Operators | ||
| Math Transform | ||
| Momentum Indicators | ||
| Overlap Studies | ||
| Pattern Recognition | ||
| Price Transform | ||
| Statistic Functions | ||
| Volatility Indicators | ||
| Volume Indicators |
About Amicus Therapeutics Predictive Indicators
The successful prediction of Amicus Therapeutics stock price could yield a significant profit to investors. But is it possible? The efficient-market hypothesis suggests that all published stock prices of traded companies, such as Amicus Therapeutics, already reflect all publicly available information. This academic statement is a fundamental principle of many financial and investing theories used today. However, the typical investor usually disagrees with a 'textbook' version of this hypothesis and continually tries to find mispriced stocks to increase returns. We use internally-developed statistical techniques to arrive at the intrinsic value of Amicus Therapeutics based on analysis of Amicus Therapeutics hews, social hype, general headline patterns, and widely used predictive technical indicators.
We also calculate exposure to Amicus Therapeutics's market risk, different technical and fundamental indicators, relevant financial multiples and ratios, and then comparing them to Amicus Therapeutics's related companies. | 2023 | 2024 | 2025 | 2026 (projected) | Payables Turnover | 2.47 | 4.09 | 4.7 | 2.98 | Days Of Inventory On Hand | 583.75 | 818.91 | 941.74 | 532.3 |
Also Currently Popular
Analyzing currently trending equities could be an opportunity to develop a better portfolio based on different market momentums that they can trigger. Utilizing the top trending stocks is also useful when creating a market-neutral strategy or pair trading technique involving a short or a long position in a currently trending equity.Complementary Tools for Amicus Stock analysis
When running Amicus Therapeutics' price analysis, check to measure Amicus Therapeutics' market volatility, profitability, liquidity, solvency, efficiency, growth potential, financial leverage, and other vital indicators. We have many different tools that can be utilized to determine how healthy Amicus Therapeutics is operating at the current time. Most of Amicus Therapeutics' value examination focuses on studying past and present price action to predict the probability of Amicus Therapeutics' future price movements. You can analyze the entity against its peers and the financial market as a whole to determine factors that move Amicus Therapeutics' price. Additionally, you may evaluate how the addition of Amicus Therapeutics to your portfolios can decrease your overall portfolio volatility.
| Money Managers Screen money managers from public funds and ETFs managed around the world | |
| Stock Tickers Use high-impact, comprehensive, and customizable stock tickers that can be easily integrated to any websites | |
| Equity Analysis Research over 250,000 global equities including funds, stocks and ETFs to find investment opportunities | |
| Price Transformation Use Price Transformation models to analyze the depth of different equity instruments across global markets | |
| Bonds Directory Find actively traded corporate debentures issued by US companies |